Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system
- PMID: 29246145
- PMCID: PMC5732474
- DOI: 10.1186/s12890-017-0559-3
Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system
Abstract
Background: Because of a limited number of reports, we aimed to investigate the clinical characteristics of patients with Legionella pneumonia due to non-Legionella pneumophila serogroup 1 and the diagnostic usefulness of the six-point scoring system for such patients compared with patients with pneumonia caused by L. pneumophila serogroup 1.
Methods: We retrospectively analysed patients diagnosed with Legionella pneumonia due to non-L. pneumophila serogroup 1 between March 2001 and June 2016. We examined the clinical characteristics, including symptoms, laboratory findings, radiologic findings, pneumonia severity, initial treatment and prognosis. We also calculated scores using the six-point scoring system in these patients. Furthermore, we compared the clinical characteristics and six-point scores between non-L. pneumophila serogroup 1 patients and L. pneumophila serogroup 1 patients among hospitalized community-acquired pneumonia patients enrolled prospectively between October 2010 and July 2016.
Results: Eleven patients had pneumonia due to non-L. pneumophila serogroup 1; their median age was 66 years and 8 patients (72.7%) were male. The most common pathogen was L. pneumophila serogroup 3 (6/11), followed by L. pneumophila serogroup 9 (3/11), L. pneumophila serogroup 6 (1/11) and L. longbeachae (1/11). Non-specific symptoms, such as fever and cough, were common. Six patients (54.5%) had liver enzyme elevation, but no patient developed hyponatraemia at <130 mEq/L. Nine patients (81.8%) showed lobar pneumonia and 7 patients (63.6%) manifested with consolidation and ground-glass opacity. Patients with mild to moderate severity comprised 10 (90.9%) by CURB-65 and 5 (45.5%) by the Pneumonia Severity Index. Of all patients, 4 were admitted to the intensive care unit and 3 died despite appropriate empiric therapy. The clinical characteristics were not significantly different between non-L. pneumophila serogroup 1 patients and L. pneumophila serogroup 1 patients (n = 23). At a cut-off value of ≥ 2 points, the sensitivity of the six-point scoring system was 54.5% (6/11) for non-L. pneumophila serogroup 1 patients and 95.7% (22/23) for L. pneumophila serogroup 1 patients.
Conclusions: Cases of non-L. pneumophila serogroup 1 pneumonia varied in severity from mild to severe and the clinical characteristics were often non-specific. The six-point scoring system was not useful in predicting such Legionella pneumonia cases.
Keywords: Community-acquired pneumonia; Diagnostic scoring system; Legionella pneumonia; Legionella pneumophila serogroup 1.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the institutional review board of Kurashiki Central Hospital (approval number 2364). All patients gave their informed consent to participate in this study.
Consent for publication
Consent for publication was not required because all patient data were anonymised.
Competing interests
Tadashi Ishida has received honoraria from Pfizer, Japan, Inc. The other authors have no conflicts of interest to declare.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Severe community-acquired pneumonia due to Legionella pneumophila Serogroup 6.J Formos Med Assoc. 2006 Mar;105(3):256-62. doi: 10.1016/S0929-6646(09)60316-8. J Formos Med Assoc. 2006. PMID: 16520845
-
A Case of Community-Acquired Pneumonia Due to Legionella pneumophila Serogroup 9 Wherein Initial Treatment with Single-Dose Oral Azithromycin Appeared Useful.Jpn J Infect Dis. 2017 Nov 22;70(6):660-662. doi: 10.7883/yoken.JJID.2016.548. Epub 2017 Sep 11. Jpn J Infect Dis. 2017. PMID: 28890505
-
[Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].Enferm Infecc Microbiol Clin. 2003 Oct;21(8):394-400. Enferm Infecc Microbiol Clin. 2003. PMID: 14525703 Review. Spanish.
-
A case of pneumonia caused by Legionella pneumophila serogroup 12 and treated successfully with imipenem.J Infect Chemother. 2014 Jun;20(6):390-3. doi: 10.1016/j.jiac.2014.01.010. Epub 2014 Mar 12. J Infect Chemother. 2014. PMID: 24629522
-
Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations.Infect Dis Clin North Am. 2017 Mar;31(1):111-121. doi: 10.1016/j.idc.2016.10.009. Infect Dis Clin North Am. 2017. PMID: 28159171 Free PMC article. Review.
Cited by
-
A community-acquired Legionnaires' disease outbreak caused by Legionella pneumophila serogroup 2: an uncommon event, Italy, August to October 2018.Euro Surveill. 2021 Jun;26(25):2001961. doi: 10.2807/1560-7917.ES.2021.26.25.2001961. Euro Surveill. 2021. PMID: 34169820 Free PMC article.
-
Hyponatremia in Infectious Diseases-A Literature Review.Int J Environ Res Public Health. 2020 Jul 23;17(15):5320. doi: 10.3390/ijerph17155320. Int J Environ Res Public Health. 2020. PMID: 32718076 Free PMC article. Review.
-
Severe Bacterial Pneumonia Due to Legionella longbeachae Transmitted from Potting Soil in Japan.Intern Med. 2024 Jul 1;63(13):1951-1957. doi: 10.2169/internalmedicine.2590-23. Epub 2023 Nov 27. Intern Med. 2024. PMID: 38008456 Free PMC article.
-
Non-Legionella pneumophila serogroup 1 pneumonia: Diagnosis of a nosocomial legionellosis with the Biofire Pneumonia plus panel.IDCases. 2022 Mar 25;28:e01487. doi: 10.1016/j.idcr.2022.e01487. eCollection 2022. IDCases. 2022. PMID: 35369568 Free PMC article.
-
Legionellosis Caused by Non-Legionella pneumophila Species, with a Focus on Legionella longbeachae.Microorganisms. 2021 Jan 31;9(2):291. doi: 10.3390/microorganisms9020291. Microorganisms. 2021. PMID: 33572638 Free PMC article. Review.
References
-
- Amemura-Maekawa J, Kura F, Helbig JH, Chang B, Kaneko A, Watanabe Y, et al. Characterization of Legionella pneumophila isolates from patients in Japan according to serogroups, monoclonal antibody subgroups and sequence types. J Med Microbiol. 2010;59:653–659. doi: 10.1099/jmm.0.017509-0. - DOI - PubMed
-
- Helbig JH, Bernander S, Castellani P, Etienne J, Gaia V, Lauwers S, et al. Pan-European study on culture-proven legionnaires’ disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis. 2002;21:710–716. doi: 10.1007/s10096-002-0820-3. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical